Eli Lilly Will Start Selling Cialis Impotency Pill in Japan (Japan)
This article was originally published in PharmAsia News
Executive Summary
Eli Lilly is now selling its Cialis impotency pill in Japan, and has increased its sales force in Japan by 100 to 900 in April. The drug firm's goal is to move from its current spot of 26th to become one of the 20 largest drugmakers in Japan by 2010. "Cialis plays an important role not just in its total sales, but it's also important in terms of capability building," says Newton Crenshaw, president of Eli Lilly's Japanese unit. "We are working hard to expand our efforts to the GP and small-clinic market." Drug sales increased in 2005 the most in 14 years, spurred by the nation's aging population, according to a PricewaterhouseCoopers report. Lilly estimates about 15 billion yen worth of treatments for erectile dysfunction are imported directly by Japanese users each year. Lilly's Japan unit increased revenue by 7 percent to 82.2 billion yen in the year ended Dec. 31, driven by an 11 percent jump in sales of the Zyprexa schizophrenia medicine. (Click here for more - May Require Free Registration